World's Best Scientists 2026 revealed!
Award Badge
Immunology
Belgium
2026

D-Index & Metrics

Immunology

D-Index
115
Citations
45831
World Ranking
399
National Ranking
3

Medicine

D-Index
115
Citations
46463
World Ranking
4569
National Ranking
46

Guy Brusselle publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Guy Brusselle sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 612 publications — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Guy Brusselle D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Guy Brusselle sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 115 D-Index — 92nd percentile

92% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in Belgium Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award
  • 2023 - Research.com Immunology in Belgium Leader Award
  • 2022 - Research.com Immunology in Belgium Leader Award

Overview

Guy Brusselle is affiliated with the Ghent University Hospital in Belgium and has a substantial body of research focused primarily in the field of Medicine, with specific expertise in Pulmonary and Respiratory Medicine, Physiology, Molecular Biology, Immunology, and Immunology and Allergy. Their research topics span asthma and respiratory diseases, chronic obstructive pulmonary disease (COPD), respiratory and cough-related research, inhalation and respiratory drug delivery, allergic rhinitis and sensitization, IL-33, ST2, and ILC pathways, and eosinophilic esophagitis.

Their frequent co-authors include Lies Lahousse, Giorgio Walter Canonica, Ken R. Bracke, Liam G. Heaney, and Ian Pavord. Their work is often published in prominent journals such as the European Respiratory Journal, ERJ Open Research, the American Journal of Respiratory and Critical Care Medicine, The Journal of Allergy and Clinical Immunology In Practice, and The Lancet Respiratory Medicine.

Recent notable publications by the scientist include:

  • Global Initiative for Asthma Strategy 2021: executive summary and rationale for key changes (2021), European Respiratory Journal
  • Objectives, design and main findings until 2020 from the Rotterdam Study (2020), European Journal of Epidemiology
  • Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update (2023), npj Primary Care Respiratory Medicine
  • Eosinophilic and Noneosinophilic Asthma (2021), CHEST Journal
  • Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial (2020), The Lancet Respiratory Medicine

Guy Brusselle has also contributed to book publications, including a work titled Diagnosis of asthma in adults (expected in 2025) published by the European Respiratory Society.

Best Publications

  • Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

    Hector G. Ortega;Mark C. Liu;Ian D. Pavord;Guy G. Brusselle

  • The Rotterdam Study: Objectives and design update

    Albert Hofman;Guy G. O. Brusselle;Sarwa Darwish Murad;Cornelia M. van Duijn

  • Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

    Mario Castro;James Zangrilli;Michael E Wechsler;Eric D Bateman

  • Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma.

    Klaus F. Rabe;Parameswaran Nair;Guy Brusselle;Jorge F. Maspero

  • After asthma: redefining airways diseases

    Ian D Pavord;Richard Beasley;Alvar Agusti;Gary P Anderson

  • Treatable traits: toward precision medicine of chronic airway diseases.

    Alvar Agusti;Elisabeth Bel;Mike Thomas;Claus Vogelmeier

  • New insights into the immunology of chronic obstructive pulmonary disease

    Guy G Brusselle;Guy F Joos;Ken R Bracke

  • Global Initiative for Asthma (GINA) Strategy 2021 – Executive summary and rationale for key changes

    Helen K. Reddel;Helen K. Reddel;Leonard B. Bacharier;Leonard B. Bacharier;Eric D. Bateman;Eric D. Bateman;Christopher E. Brightling;Christopher E. Brightling

  • Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma

    Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme

  • Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function

    Dana B. Hancock;Mark Eijgelsheim;Jemma B. Wilk;Sina A. Gharib

  • Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema

    Ingel K Demedts;Tine Demoor;Ken R Bracke;Guy F Joos

  • Attenuation of allergic airway inflammation in IL-4 deficient mice.

    G G Brusselle;J C Kips;J H Tavernier;J G van der Heyden

  • Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial

    Guy G Brusselle;Christine VanderStichele;Paul Jordens;René Deman

  • Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

    Jean Bousquet;Holger J. Schünemann;Akdis Togias;Claus Bachert

  • Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks

    Florence Demenais;Florence Demenais;Patricia Margaritte-Jeannin;Patricia Margaritte-Jeannin;Kathleen C. Barnes;William O.C. Cookson

  • Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function

    María Soler Artigas;Daan W. Loth;Louise V. Wain;Sina A. Gharib

  • The Rotterdam Study: 2018 update on objectives, design and main results.

    M. Arfan Ikram;Guy G. O. Brusselle;Guy G. O. Brusselle;Sarwa Darwish Murad;Cornelia M. van Duijn

  • ALLERGEN-INDUCED AIRWAY INFLAMMATION AND BRONCHIAL RESPONSIVENESS IN WILD-TYPE AND INTERLEUKIN-4-DEFICIENT MICE

    Guy Brusselle;Johan Kips;Guy Joos;H Bluethmann

  • Objectives, design and main findings until 2020 from the Rotterdam Study.

    M Arfan Ikram;Guy Brusselle;Guy Brusselle;Mohsen Ghanbari;André Goedegebure

  • Properties of the COPD assessment test in a cross-sectional European study

    P W Jones;G Brusselle;R W Dal Negro;M Ferrer

  • Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease

    G G Brusselle;G F Joos;K R Bracke;Guy G Brusselle

  • Omalizumab is effective in allergic and non-allergic patients with nasal polyps and asthma

    Philippe Gevaert;Lien Calus;Thibaut Van Zele;Katrien Blomme

  • Multiancestry association study identifies new asthma risk loci that colocalize with immune-cell enhancer marks

    Florence Demenais;Patricia Margaritte-Jeannin;Kathleen C. Barnes;William O. C. Cookson

Frequent Co-Authors

Ken R. Bracke
Ken R. Bracke Ghent University Hospital
Guy Joos
Guy Joos Ghent University Hospital
Bruno H. Stricker
Bruno H. Stricker Erasmus University Rotterdam
Albert Hofman
Albert Hofman Harvard University
Guy Joos
Guy Joos Ghent University Hospital
George T. O'Connor
George T. O'Connor Boston University
David Price
David Price University of Aberdeen
André G. Uitterlinden
André G. Uitterlinden Erasmus University Rotterdam
Oscar H. Franco
Oscar H. Franco University Medical Center Utrecht
Josée Dupuis
Josée Dupuis McGill University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers. For those interested in clinical practice, pursuing advanced nursing qualifications can be a strategic step. Many professionals transition into specialized roles, such as through the acute care nurse practitioner certification, which equips nurses with skills to manage complex patient cases in hospital settings.

Accelerated nursing programs offer efficient routes to advance your healthcare career. Options like the accelerated np program allow registered nurses and other qualified individuals to become nurse practitioners swiftly without compromising on education quality.

For those without prior nursing experience, enrolling in online accelerated nursing programs for non nurses can be an excellent way to enter the healthcare field. These programs cater specifically to individuals aiming for a nursing career through condensed, flexible study plans.

Additionally, 12-month accelerated nursing programs provide an intensive yet accessible path for students looking to quickly earn their Bachelor of Science in Nursing (BSN). These programs blend fast-paced coursework with practical experience, ideal for motivated learners.

Overall, combining immunology studies with these nursing education options can create robust career pathways in both clinical care and biomedical research sectors.

Best Scientists Citing Guy Brusselle

Trending Scientists

Recently Published Articles